Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation

Condition:   COPD Exacerbation Interventions:   Drug: 5 days of systemic corticotherapy (prednisone);   Drug: 5 days of placebo Sponsor:   University Hospital, Montpellier Not yet recruiting

Source: ClinicalTrials.gov - January 20, 2020 Category: Research Source Type: clinical trials